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Abstract
Fanconi anemia (FA) is a rare genetic disease characterized by congenital defects, bone marrow failure,
chromosomal instability, and cancer susceptibility. One hallmark of cells from FA patients is
hypersensitivity to interstrand cross-linking agents, such as the chemotherapeutics cisplatin and
mitomycin C (MMC). We have recently characterized a FANCD2/FANCI-associated nuclease,
KIAA1018/FAN1, the depletion of which sensitizes human cells to these agents. However, as the
down-regulation of FAN1 in human cells was mediated by siRNA and thus only transient, we were
unable to study the long-term effects of FAN1 loss on chromosomal stability. We now describe the
generation of chicken DT40 B cells, in which the FAN1 locus was disrupted by gene targeting.
FAN1-null cells are highly sensitive to cisplatin and MMC, but not to ionizing or UV radiation, methyl
methanesulfonate, or camptothecin. The cells do not display elevated sister chromatid exchange
frequencies, either sporadic or MMC-induced. Interestingly, MMC treatment causes chromosomal
instability that is quantitatively, but not qualitatively, comparable to that seen in FA cells. This finding,
coupled with evidence showing that DT40 cells deficient in both FAN1 and FANCC, or FAN1 and
FANCJ, exhibited increased sensitivity to cisplatin compared with cells lacking only FAN1, suggests
that, despite its association with FANCD2/FANCI, FAN1 in DT40 cells participates in the processing of
damage induced by interstrand cross-linking-generating agents also independently of the classical FA
pathway.
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Fanconi anemia (FA) is a rare genetic disease characterized by
congenital defects, bone marrow failure, chromosomal instability,
and cancer susceptibility. One hallmark of cells from FA patients is
hypersensitivity to interstrand cross-linking agents, such as the
chemotherapeutics cisplatin and mitomycin C (MMC). We have
recently characterized a FANCD2/FANCI-associated nuclease,
KIAA1018/FAN1, the depletion of which sensitizes human cells to
these agents. However, as the down-regulation of FAN1 in human
cells was mediated by siRNA and thus only transient, we were
unable to study the long-term effects of FAN1 loss on chromo-
somal stability. We now describe the generation of chicken DT40 B
cells, in which the FAN1 locus was disrupted by gene targeting.
FAN1-null cells are highly sensitive to cisplatin and MMC, but not
to ionizing or UV radiation, methyl methanesulfonate, or campto-
thecin. The cells do not display elevated sister chromatid exchange
frequencies, either sporadic or MMC-induced. Interestingly, MMC
treatment causes chromosomal instability that is quantitatively,
but not qualitatively, comparable to that seen in FA cells. This
finding, coupled with evidence showing that DT40 cells deficient
in both FAN1 and FANCC, or FAN1 and FANCJ, exhibited increased
sensitivity to cisplatin compared with cells lacking only FAN1, sug-
gests that, despite its association with FANCD2/FANCI, FAN1 in
DT40 cells participates in the processing of damage induced by
interstrand cross-linking-generating agents also independently of
the classical FA pathway.
The mismatch repair (MMR) system has evolved to controlthe fidelity of DNA replication and recombination. Corre-
spondingly, MMR malfunction in all organisms is associated with
an up to 1,000-fold increase in mutation frequency and a hyper-
recombination phenotype. Unexpectedly, studies involving pri-
marily knockout mice also implicated MMR genes in other
processes of DNA metabolism, ranging from DNA damage sig-
naling to hypermutation of Ig genes, where the molecular roles
of MMR proteins are unclear (1). We argued that character-
ization of the MMR interactome might provide us with new
insights into these phenomena. Among the interactors of MLH1
and PMS2 (2), we found an evolutionarily highly conserved hy-
pothetical protein KIAA1018 (Fig. 1) predicted to contain
a ubiquitin-binding zinc-finger (UBZ) domain (3), as well as
a PD-(D/E)XK motif found in a superfamily of restriction and
repair nucleases (4, 5). This polypeptide attracted our interest,
because eukaryotic MMR has to date been shown to involve only
a single exonuclease, EXO1 (6), whereas Escherichia coli deploys
several such enzymatic activities. We therefore set out to char-
acterize KIAA1018 biochemically and to study its biological role.
Surprisingly, siRNA-mediated knockdown of KIAA1018 in hu-
man cells did not give rise to any phenotypic trait associated with
MMR deficiency, but rather led to a hypersensitivity specific to
cisplatin and mitomycin C (MMC) (7–10). These agents modify
predominantly guanine residues in DNA and form, in addition to
monoadducts and intrastrand cross-links, interstrand cross-links
(ICLs) that block the progression of replication and transcrip-
tion. The repair of ICLs at replication forks is complex, inasmuch
as it involves proteins from different pathways of DNA metab-
olism. In higher eukaryotes, this process is coordinated by the
Fanconi anemia (FA) pathway, where the ATR kinase activates
the FA core complex (consisting of FANCA, B, C, E, F, G, L,
and M) to monoubiquitylate the FANCD2/FANCI heterodimer
and thus license it to recruit other repair factors to the damage (11).
As KIAA1018 (henceforth referred to as FANCD2/FANCI-
associated nuclease; FAN1) recruitment to DNA damage-in-
duced foci was dependent on monoubiquitylated FANCD2/
FANCI, FAN1 was proposed to be linked to the FA pathway of
DNA damage processing (7–10). These studies also suggested
that FAN1 might be involved in homologous recombination and
in the maintenance of chromosomal stability. However, given the
transient nature of siRNA knockdowns, we decided to disrupt
the KIAA1018/FAN1 locus in chicken DT40 cells and to study
the phenotype of the FAN1-deficient cells in this stable system.
We also set out to establish whether the FAN1-deficient phe-
notype is epistatic with that of FA.
Results
Avian FAN1 Is a Nuclease. To test whether chicken FAN1 is indeed
a nuclease as predicted by bioinformatic analysis (4, 5) and
whether it shares its substrate specificity with the human poly-
peptide, we expressed in Sf9 cells the wild-type chicken protein
as well as a mutant carrying an aspartate-to-alanine substitution
(D977A) in the putative nuclease active site (Fig. S1A). In-
cubation of the untagged purified polypeptides (Fig. S1B) with
ΦX174 DNA, single-stranded circular substrate that contains
numerous secondary structures (hairpin loops and bulges) sus-
ceptible to cleavage by most structure-specific endonucleases in
vitro, resulted in extensive degradation of the DNA by the wild-
type enzyme but not by the D977A mutant (Fig. S1C). As the
latter protein was able to bind DNA in a gel-shift assay with an
affinity similar to the wild-type protein (Fig. S1D), we concluded
that its inactivity was linked to the mutation of the active site,
rather than to misfolding. These tests unambiguously showed that
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avian FAN1 is an endonuclease. By incubating the enzyme with
a variety of oligonucleotide substrates, we could confirm that, like
the human protein (7–10), the avian enzyme displays preference
for the 5′-flap structure, even though other branched substrates
were also cleaved, albeit less efficiently (Fig. 1). Interestingly, in-
cubation of FAN1 with the 5′-labeled 3′ flap and three-way junc-
tion substrates, which were poorly addressed by the endonuclease
as witnessed by the absence of an∼30-mer product band, gave rise
instead to rapidlymigrating labeled species that we attributed to 1-
to 4-nucleotide-long fragments. This shows that FAN1 also pos-
sesses a 5′→3′ exonuclease activity that prefers double-stranded
DNAends (Fig. 1, four left sets).We could confirm this prediction
by labeling the bottom 60-mer strands at their 3′ termini. In-
cubation with FAN1 gave rise in all cases to degradation products,
the smallest of which were∼30 nucleotides long, whichmost likely
resulted from a 5′→3′ degradation of the double-stranded regions
of the substrates up to the junctionwhere the strands separate (Fig.
1, four right sets).
Disruption of the DT40 FAN1 Locus Does Not Affect Cell Growth. The
chicken gene encodes a polypeptide of 1,034 amino acids (Fig.
S1A) that displays 52% similarity and 65% identity at the amino
acid level to its human 1,017-residue ortholog. Targeting con-
structs were generated which lacked parts of exons 2 and 3 (Fig.
S2A) encoding the putative UBZ domain. Disruption of the
FAN1 locus was confirmed by Southern blot (Fig. S2B) and RT-
PCR (Fig. S2C) analyses. The FAN1−/− and wild-type DT40 cells
displayed similar doubling times (Fig. S2D) and very similar cell-
cycle profiles (Fig. S2E). Thus, FAN1 disruption does not affect
the basal growth properties of DT40 cells.
Disruption of the FAN1 Locus Sensitizes DT40 Cells to ICL-Generating
Agents. We then measured the sensitivity of the FAN1−/− DT40
cells to a range of DNA-damaging agents. DT40 wild-type and
two independent clones of FAN1−/− cells showed similar sensi-
tivities to γ-rays, UV, methyl methanesulfonate (MMS) (Fig. S2
F–H), and camptothecin (Fig. 2A). In contrast, FAN1−/− cells
were more sensitive to cisplatin or MMC than wild-type DT40
cells (Fig. 2 B and C). The hypersensitivity to the latter reagents
could be rescued by a stable transfection of FAN1−/− clone 1 with
a vector carrying chicken wild-type FAN1 cDNA (GdFAN1) (Fig.
2 B and C). These results also agree with those obtained by
siRNA-mediated knockdown of FAN1 in human cells (7–10). In
contrast, the knockout cells could not be rescued by the ex-
pression FAN1 cDNA carrying a D977A substitution in the nu-
clease domain (Fig. S2I). Taken together, these data show that
the observed hypersensitivity to ICL-inducing agents was caused
solely by disruption of the FAN1 gene and that the nuclease
domain is essential for the function of this protein.
FAN1 Deficiency Leads to Chromosomal Instability. Hypersensitivity
to ICL-inducing agents is a common phenotypic trait of FA cells,
as is chromosomal instability, both spontaneous and damage-
induced (12). We therefore studied sister chromatid exchange
(SCE) frequencies in FAN1−/− DT40 cells. As shown in Fig. 3A,
only very small increases in spontaneous and MMC-induced
SCEs were seen in the FAN1−/− cells compared with the wild-
type DT40 control. However, a very different picture emerged
when we compared chromosomal aberrations in these two cell
lines after MMC treatment. The number of chromosomal
changes increased notably (Fig. 3B), and whereas disruption of
the FAN1 locus had little effect on spontaneous aberrations, the
number of induced chromosomal changes was approximately
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Fig. 1. Gallus FAN1 is an endonuclease. FAN1 cleaves preferentially 5′ flaps.
The wild-type (WT) enzyme or the D977A (DA) mutant was incubated with
a series of oligonucleotide substrates shown below the panel. The arrow
indicates the preferred cleavage product. The rapidly migrating radioactive
species seen at the bottom of this 20% denaturing polyacrylamide gel cor-
respond to DNA fragments 1–4 nucleotides in length. The position of the
radiolabel is indicated by an asterisk. M, marker; 3-WJ: three-way junction.
A B C
Fig. 2. FAN1-deficient DT40 cells are hypersensitive to DNA cross-linking
agents. DT40 cells of the indicated genotypes were exposed to γ-rays, UV,
MMS (Fig. S2 F–H), and camptothecin (A), cisplatin (B), and mitomycin C (C).
The doses of the agents are shown on the x axes on a linear scale, whereas
the fractions of surviving colonies are displayed on the y axis on a loga-
rithmic scale. Each data point represents an average of at least three in-
dependent experiments ±SD. #1 and #2, two independent FAN1 knockout
clones. FAN1−/−/GdFAN1 denotes a FAN1 knockout clone stably transfected
with an expression vector encoding a FAN1 ORF. As shown, expression of this
protein rescued the hypersensitive phenotype of the FAN1 knockout cells.
A
B
Fig. 3. FAN1-deficient cells display an increased rate of chromosomal
aberrations. (A) Sister chromatid exchange frequencies in wild-type and
FAN1−/− DT40 cells, either untreated or treated with 20 ng/mL MMC. The
graph shows the number of metaphases (y axis) containing a given number
of SCEs (x axis). The mean number of SCEs is indicated. At least 50 metaphase
spreads were counted for each experiment and the graph shows the mean
number of SCEs. (B) Occurrence of chromosomal aberrations in wild-type,
FAN1−/−, FANCC/−, and FANCJ−/− DT40 cells, either untreated or treated with
the indicated doses of MMC.
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threefold higher than in wild-type cells upon treatment with
20 ng/mL MMC. Under identical conditions, cells disrupted in
the FANCC and FANCJ loci displayed higher numbers of
spontaneous aberrations than FAN1−/− cells, as well as a greater
number and variety of aberrations after MMC treatment (Fig.
3B). Thus, whereas the changes observed in the wild-type and
FAN1-deficient cells were exclusively chromosomal breaks and
gaps, FANCC/− and FANCJ−/− cells displayed in addition chro-
matid aberrations, as could be expected from their increased
SCE frequencies (Fig. 3B) (13–15).
In contrast to FANCC/− cells, which displayed a lower frequency
of gene targeting than wild-type DT40 cells (Fig. S3A) (13), gene-
targeting frequencies measured at two different loci in FAN1−/−
cells were similar to those observed in the wild-type controls (Fig.
S3A). In addition, no change in the efficiency of homologous re-
combination for FAN1-deficient cells was detected in a reporter
assay which scores for neomycin resistance following the recombi-
nation between two disrupted neomycin ORFs integrated in DT40
genomic DNA that is triggered by the induction of a sequence-
specific double-strand break in one of the neomycin inserts (Fig.
S3B) (16). These results imply that FAN1 is not involved in the
control of homologous recombination in DT40 cells.
FA and FAN1 Deficiencies Are Additive Rather than Epistatic. Al-
though lack of FAN1 or FA proteins leads in both cases to hy-
persensitivity to cisplatin and MMC, the differences in the
subtypes of chromosomal aberrations described above suggested
that the enzymes might not process identical lesions or inter-
mediates generated by these agents. To test this prediction, we
generated double mutant DT40 cells. The FAN1−/−/FANCC/−
double knockout cells grewmore slowly thanwild-typeDT40 cells,
but at the same rate asFANCC/− cells (Fig. S4A). Importantly, they
displayed higher sensitivity to cisplatin than either single mutant
(Fig. 4A), and the number of MMC-induced chromosomal aber-
rations was also higher than in the single mutants (Fig. 4B).
However, the number of spontaneous SCEs in the double
knockout cells was not greater than in the FANC/− line (Fig. 4E
Left). Similarly to the FANCC/− cells, the FANCJ−/− knockout cell
line also proliferated with slower growth kinetics than wild-type
DT40 or FAN1−/− cells, and FAN1 inactivation reduced their
growth rate even further (Fig. S4B). Expression of wild-type FAN1
in these cells reverted the growth defect back to the level seen in
FANCJ−/− cells, which showed that the difference was indeed due
to the disruption of the FAN1 locus. Like the FAN1−/−/FANCC/−
clones, the FAN1−/−/FANCJ−/− cells were also more sensitive to
cisplatin than either of the single knockouts (Fig. 4C) and the
number of MMC-induced chromosomal aberrations was likewise
increased (Fig. 4D). As in the case of FANCC, SCE frequency in
FAN1−/−/FANCJ−/− cells was similar to that seen inFANCJ−/− cells
(Fig. 4E Right). This further confirmed our hypothesis that al-
though FAN1 is clearly involved in the cellular response to ICL-
inducing agents, it does not appear to be involved in the processing
of spontaneous DNA damage together with FA proteins.
FAN1 Deficiency Does Not Affect Ubiquitylation of FANCD2. Cells
lacking constituent proteins of the FA core complex fail to
monoubiquitylate the FANCD2/FANCI heterodimer upon
treatment with DNA-damaging agents (11). As shown in Fig. 5,
MMC-induced FANCD2 monoubiquitylation in FAN1−/− and in
wild-type DT40 cells was similar, in contrast to FANCC/− cells.
FAN1 is therefore not required for the activation of the ubiquitin
ligase of the FA core complex. This resembles the situation in
FANCJ-deficient cells (Fig. 5), and could indicate that FAN1,
like FANCJ, participates in DNA damage processing down-
stream of the FA complex. An alternative explanation might be
that FAN1 might not be directly linked to the FA pathway, as
implied by the data presented above.
A
B
C
D
E
Fig. 4. FAN1/FANCC and FAN1/FANCJ double knockout DT40 cells are more
sensitive to cisplatin than single mutants and display more chromosomal
aberrations. (A) FAN1−/−/FANCC/− cells are more sensitive to cisplatin than
wild-type, FAN1−/−, or FANCC/− single knockout cells. Each data point rep-
resents an average of at least three independent experiments ±SD. (B)
FAN1−/−/FANCC/− cells display more and different distribution of chromo-
somal aberrations compared with wild-type, FAN1−/−, or FANCC/− single
knockout cells. (C) FAN1−/−/FANCJ−/− cells are more sensitive to cisplatin than
wild-type, FAN1−/−, or FANCJ−/− single knockout cells. Each data point rep-
resents an average of at least three independent experiments ±SD. (D) Oc-
currence of chromosomal aberrations in FAN1−/−/FANCCJ−/− cells compared
with wild-type, FAN1−/−, or FANCJ−/− single knockout cells. (E) Sister chro-
matid exchange frequencies in wild type, FAN1−/−, FANCC/−, FANCJ−/−,
FAN1−/−/FANCC/−, or FAN1/FANCJ−/− DT40 cells. The y axis shows the number
of metaphases containing the number of SCEs indicated on the x axis. At
least 50 metaphase spreads were counted for each experiment and the
graph shows the mean number of SCEs.
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FAN1 Targeting to DNA Damage Foci Is Dependent on the FA Complex.
Treatment of cells with DNA-damaging agents frequently leads
to the accumulation of DNA damage response proteins in sub-
nuclear foci at (or close to) the sites of damage. To find out
whether FAN1 behaved similarly, we transfected DT40 cells
with a vector expressing a GFP-FAN1 fusion protein. As shown
in Fig. S5A, the untreated transfected cells contained a small
number of nuclear foci, which might represent spontaneous
DNA damage, possibly stalled replication forks. In contrast, in
MMC-treated cells, the number of these foci increased sub-
stantially. Because MMC is known to induce foci containing the
FA factors, we wanted to test whether the FAN1 foci colocalized
with those formed by FANCD2, which, together with its heter-
odimeric partner FANCI, is believed to be responsible for the
recruitment of repair proteins to blocked replication forks and
other types of DNA damage. That FANCD2 and GFP-FAN1
almost completely colocalized (Fig. S5 A and B) was somewhat
unexpected, based on the results of the experiments described
above. Even more surprising was the fact that, like FANCD2,
GFP-FAN1 failed to form MMC-induced foci when expressed in
FANCC-deficient cells. These results indicate that FAN1 and
FANCD2 are targeted to the same foci, and that this targeting
depends on a functional FA complex. However, as the ubiq-
uitylation of FANCD2 was not affected by FAN1 deficiency (Fig.
5), FAN1 appears to act downstream of FANCD2 (7–10).
Discussion
The data presented in this study confirm and extend our findings
in the human system, which showed that FAN1 is a DNA repair
enzyme that participates in the processing of lesions formed by
ICL-generating compounds (7–10).
Hypersensitivity of FA cells to ICL-inducing agents is a clinical
hallmark of Fanconi anemia. However, the slower growth and
spontaneous chromosomal instability of FA cells imply that the
pathway evolved to deal with endogenous damage, such as DNA
adducts arising through reactions with lipid peroxidation by-
products, or complex secondary structures that hinder replica-
tion, such as hairpins that might arise in regions of dyad sym-
metry or in triplet repeats (17, 18) and that can give rise to
chromosomal instability if uncorrected. These lesions are ap-
parently not addressed by FAN1, given that cells lacking this
protein divide with similar kinetics to wild-type DT40 cells (Fig.
S2D) and display normal spontaneous SCE frequency (Fig. 3A).
Further evidence in support of this hypothesis came from the
findings that disruption of the FAN1 locus in FANCC/− or
FANCJ−/− cells gave rise to no significant increase in the fre-
quency of SCEs (Fig. 4E). These aberrations are believed to arise
through reciprocal exchange of genetic material, where Holliday
junctions generated by homologous recombination at arrested or
blocked replication forks are resolved to yield cross-over prod-
ucts. Such a situation is prevented primarily by the BLM/Top-
oIIIα/RMI1 complex and, consequently, BLM-deficient cells
exhibit high SCE frequencies. The recruitment of the latter
complex to replication forks was recently reported to be medi-
ated (at least in part) by the FANCM protein (19), and this might
explain why defects in the FA pathway give rise to SCEs. This
evidence might also imply that FAN1 is not recruited or required
at these spontaneous replication blocks.
On the other hand, FAN1 is recruited to foci induced by ICL-
generating agents, where it most likely acts in the cleavage of
cross-linked DNA molecules. It is interesting to note that the 5′-
flap preference of FAN1 complements the 3′-flap selectivity of
MUS81/EME1 or XPF/ERCC1 (20–22), the other nucleases
implicated in ICL repair, and thus that these enzymes might act
in concert to release or “unhook” the cross-linked strand to allow
for bypass of the lesion.
The finding that recruitment of chicken and human FAN1 to
DNA damage foci is dependent on FA complex activation im-
plies a close association with the Fanconi anemia pathway in
the processing of induced damage. Here, however, there were
differences between human and chicken cells. In the former,
siRNA-mediated knockdown of FANCD2 and FAN1 brought
about similar hypersensitivity to ICL-generating compounds as
seen in the single knockdowns (7). In contrast, the sensitivities of
DT40 FAN1/FANCC and FAN1/FANCJ double mutants to cis-
platin or MMC were greater than those of the single knockout
cell lines (Fig. 4 A and C). Interestingly, a similar phenomenon
was reported also for the FANCC/FANCJ double mutant in
DT40 cells (15). This suggests that, in chicken DT40 cells, the
roles of the FA pathway do not fully overlap with those of FAN1
or FANCJ. Thus, although the FA complex in human cells
appears to recruit to blocked replication forks all proteins that
are necessary for their rescue, the processing of damage induced
by cross-linking agents in chicken cells appears to be channeled
into different pathways, some of which involve the FA complex
and others not. Although this scenario might appear unlikely due
to the high degree of evolutionary conservation of the FA
pathway in higher eukaryotes, the FAN1 nuclease motif evolved
earlier, as its homologs are found already in Schizosaccharomyces
pombe and Pseudomonas aeruginosa. The latter proteins contain
the endonuclease domain but not the zinc-finger motif that is
required for interaction with FANCD2 (8); it will therefore be
interesting to learn whether these FAN1 homologs are involved
in ICL processing in these monocellular organisms.
Fanconi anemia is a rare genetic disease characterized by
congenital defects, bone marrow failure, chromosomal instabil-
ity, and cancer susceptibility (11). Given that untreated FAN1-
deficient cells do not display proliferation defects, the likelihood
that individuals with inactivating mutations in FAN1 will present
with an FA-like syndrome may be low. It is also possible that
FAN1 is functionally at least partially redundant with other, as
yet unidentified, nucleases. Functional redundancy might help
explain why genes encoding XPF/ERCC1 or MUS81/EME1 (20–
22) have not been found mutated in FA patients. However, it is
likely that FAN1 will turn out to be clinically important, as its
loss clearly sensitizes cells to ICL-generating drugs. Given that
MMC and especially the platinum compounds cisplatin, oxali-
platin, and carboplatin are in increasing use in the therapy of
a broad range of cancers (23, 24), elucidation of the biological
role of this enzyme in the metabolism of ICLs is of substantial
clinical importance. By generating multiple knockout lines, the
DT40 system should allow us to dissect ICL processing further,
and thus provide us with insights into this important pathway of
DNA metabolism.
Methods
Accession codes, cDNA, protein purification, and standard procedures are
described in SI Text.
Specific Nuclease Assay. One nanomole of labeled substrate was incubated
with 10 nmol of FAN1 wild-type or D977A mutant in 25 mM Hepes·KOH (pH
7.4), 25 mM KCl, 1 mM MgCl2 as indicated, and 0.05 mg/mL BSA for 30 min
at 37 °C. The reaction was terminated with 0.1% SDS, 14 mM EDTA, and
FANCD2
Ub-FANCD2 
-       + -     + -      + -      +MMC 
Fig. 5. Damage-induced FANCD2 monoubiquitylation is unaffected by
FAN1 status. In MMC-treated cells, FANCD2 is monoubiquitylated, as wit-
nessed by its slower migration through a denaturing polyacrylamide gel.
This posttranslational modification was not detected in FANCC-deficient
cells, but was in cells lacking FAN1 or FANCJ.
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0.1 mg/mL proteinase K and incubation at 55 °C for 15 min. Loading buffer
was added and the samples were denatured and separated on a 20% de-
naturing polyacrylamide gel for 1 h at 40 V/cm. The gels were dried and the
bands were visualized on a PhosphorImager (Typhoon 9400; GE Healthcare).
Proliferation Analysis and Sensitivity Assay. The experimental methods for
proliferation analysis and sensitivity assays were performed as described
previously (16). To measure the sensitivity of DT40 double knockout FAN1/
FANCC and FAN1/FANCJ cells, cells were cultured in medium containing cis-
platin. The experimental methods for cell counting and cell-cycle analysis
were described previously (16).
Chromosomal Aberration Analysis. Preparation of chromosome spreads and
karyotype analysis were performed as described previously (25). To measure
mitomycin C-induced chromosomal aberrations, cells were incubated with
2.5, 5, 10, and 20 ng/mL mitomycin C for 24 h before harvest and fixation.
Cells were incubated with colcemid (final concentration, 0.1 μg/mL) for the
last 2 h to enrich for mitotic cells.
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